Optimize Your UK Clinical Trial Imports

The UK is one of the world’s most established clinical research markets, consistently ranking among the top destinations for global sponsors. With a robust healthcare system, highly skilled investigators, and internationally recognized regulatory oversight from the Medicines and Healthcare products Regulatory Agency (MHRA), the UK offers an environment of trust, reliability, and scale.

However, importing clinical trial materials into the UK demands careful management. Investigational medicinal products (IMPs) require MHRA approval, medical devices must carry CE or UKCA marking, and customs officials enforce strict documentation standards. Beyond compliance, the UK’s 20% VAT on imports can create a significant financial burden for sponsors, unless properly managed through reclaim or exemption structures.

This combination of high standards and cost exposure makes the UK both a critical market and a complex one. With the right partner, sponsors can unlock the UK’s opportunities while avoiding regulatory and financial pitfalls.

Race Against Time: Enabling Patient Dosing on Schedule

A major gene therapy sponsor was running a UK-based clinical trial with bulk IMP shipments stored at a central depot. After two successful shipments, an urgent issue arose: a site delivery experienced a temperature excursion, jeopardizing a patient’s upcoming dosing visit.

The timing could not have been worse, as the notification came in on a Friday, with the patient scheduled for dosing the following Wednesday. As the patient had already initiated immunosuppressants, any delay in receiving the IMP would have had critical consequences for treatment.

TecEx Medical mobilized immediately. Our team secured freight provider approval the same day, coordinated clearances the following Monday, and worked directly with the relevant stakeholders to ensure delivery reached the site on time.

Within just a few days, the shipment was cleared, released, and routed successfully, enabling the patient to receive their IMP within the correct dosing window. By acting decisively across freight, customs, and depot coordination, TecEx Medical ensured that trial continuity and patient care were protected under extraordinary time pressure.

Unlocking VAT Savings Through a Streamlined Solution

At the beginning of its UK operations, our client had established a local entity and VAT registration, intending to manage the VAT and IOR requirements directly. However, this approach quickly ran into challenges. The sponsor experienced operational difficulties coordinating between different providers, and critically, VAT was charged in a way that made recovery impossible. The complexity of the payment flows left the client unable to reclaim the VAT at all.

TecEx Medical stepped in to design a more efficient solution. Working closely with their finance team, we developed a streamlined import VAT process that removed the administrative burden from their internal teams and eliminated the uncertainty around recovery. Our approach ensured VAT was handled correctly upfront, freeing the client to focus on the science and operations of their trial.

As a result, they avoided further unrecoverable VAT costs and gained confidence that imports into the UK would be both compliant and financially optimized. The solution provided lasting value by reducing risk and giving the sponsor’s team clarity and bandwidth to concentrate on patient outcomes.